Clinical Takeaway In this pilot study, short-term low-dose CBD supplementation did not measurably improve glucose tolerance or beneficially alter the gut microbiome in sedentary adults with overweight or obesity. While animal research...
endocannabinoid system clinical research: CBD & Metabolic Health
Clinical Takeaway In this pilot study, short-term low-dose CBD supplementation did not produce measurable improvements in glucose tolerance, gut microbiome composition, or inflammation markers in sedentary adults with overweight or obesity. While...
Cannabidiol & Glucose Tolerance: Clinical Research Review
Clinical Takeaway In this pilot study, short-term low-dose oral CBD did not produce measurable improvements in glucose tolerance, gut microbiome composition, or inflammatory markers in sedentary adults with overweight or obesity. While...
endocannabinoid system clinical research: CBD & Metabolic Health
Clinical Takeaway In this pilot study, short-term low-dose oral CBD did not improve glucose tolerance or meaningfully alter gut microbiome composition in sedentary adults with overweight or obesity. While epidemiological data suggest...
endocannabinoid system clinical research: CBD & Metabolism
Clinical Takeaway In this pilot study, short-term low-dose CBD supplementation did not produce measurable improvements in glucose tolerance, gut microbiome composition, or inflammation markers in sedentary adults with overweight or obesity. While...